Capricor Therapeutics | CAPR - Operating Profit


Capricor Therapeutics reported $-29.16M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -7.77M 2.99M Jun/2023
Bioline Rx USD -2.21M 96K Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Geron USD -10.79M 3.1M Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -25.73M 2.91M Sep/2024
J&J USD 5.59B 1.81B Dec/2025
Prothena USD -27.21M 12.55M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025